Monte Rosa Therapeutics Inc (GLUE)

Total Costs & Expenses

$210.58M

TTM · Period ending: · USD

GLUE logo

GLUE Total Costs & Expenses

Latest reported$210.58M
GLUE TTM Total Costs & Expenses ($28.01M → $210.58M)
High-resolution chart · PNG

GLUE total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Monte Rosa Therapeutics Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
210,581,000
191,231,000
177,880,000
173,027,000
163,027,000
161,616,000
156,734,000
143,954,000
145,179,000
145,063,000
143,311,000
140,937,000
132,331,000
122,341,000
112,384,000
103,282,000
94,788,000
85,680,000
72,882,000
61,431,000
47,949,000
35,222,000
28,011,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.